跳至主要内容
临床试验/NCT02217787
NCT02217787已完成1 期

A Phase 1, Cross-over, Randomized, Single-dose Open Label Study To Determine The Effect Of Food On The Pharmacokinetics Of Orally Administered Pf-06372865 In Healthy Adult Subjects

Pfizer1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
12
试验地点
1
主要终点
Maximum Observed Plasma Concentration (Cmax)

研究概览

简要总结

This study has been designed to investigate the effect of high fat food on the pharmacokinetics of PF-06372865 when administered to healthy subjects as single oral doses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male and/or female subjects of non-childbearing potential between the ages of 18 and 55 years, inclusive
  • Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs);

排除标准

  • Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease
  • Screening supine blood pressure > 140 mm Hg (systolic) or >90 mm Hg (diastolic), following at least 5 minutes of supine rest.
  • Any condition possibly affecting drug absorption: current or recent (within one year) gastrointestinal disease; a history of malabsorption, esophageal reflux, irritable bowel syndrome; frequent (more than once a week) occurrence of heartburn; or any surgical intervention (e.g., cholecysectomy) which would be expected to influence the absorption of drugs.

研究组 & 干预措施

fasted condition

Other

干预措施: PF-06372865 (Drug)

fed condition

Other

干预措施: PF-06372865 (Drug)

结局指标

主要结局

Maximum Observed Plasma Concentration (Cmax)

时间窗: basline to 48 hours

Time to Reach Maximum Observed Plasma Concentration (Tmax)

时间窗: basline to 48 hours

Area Under the Curve From Time Zero to Extrapolated Infinite Time [AUC (0 - 8)]

时间窗: basline to 48 hours

AUC (0 - 8)= Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - 8). It is obtained from AUC (0 - t) plus AUC (t - 8).

Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast)

时间窗: basline to 48 hours

Area under the plasma concentration time-curve from zero to the last measured concentration (AUClast)

Plasma Decay Half-Life (t1/2)

时间窗: basline to 48 hours

Plasma decay half-life is the time measured for the plasma concentration to decrease by one half.

次要结局

  • Change from Baseline in Systolic Blood Pressure(basline to 48 hours)
  • Change from Baseline in Diastolic Blood Pressure(basline to 48 hours)
  • Change from baseline in heart rate(basline to 48 hours)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验